Case report: an unusual long-term evolution of a diffuse midline glioma, H3K27 altered
BackgroundAs diffuse midline glioma, H3K27 altered, is a rare tumor entity with poor prognosis and few therapeutic options, only little is known so far about the genetic factors that influence tumorigenesis and the course of tumor development.PresentationWe present the case of a 38-year-old female p...
Saved in:
Main Authors: | Michael Griessmair, Claire Delbridge, Claus Zimmer, Eva Mayr, Arthur Wagner, Julian Canisius, Marie-Christin Metz, Benedikt Wiestler |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1480247/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unraveling the heterogeneity of WHO grade 4 gliomas: insights from clinical, imaging, and molecular characterization
by: Haihui Jiang, et al.
Published: (2025-02-01) -
Expression of EZH2 and H3K27me3 predicts tumor biology of urothelial carcinoma
by: Rasheeda Mohamedali, et al.
Published: (2023-07-01) -
Bisphenol B restrains rat leydig cell function via H3K27me3/H3K9me3 histone modifications
by: Jiayi He, et al.
Published: (2025-02-01) -
Prmt5 is essential for intestinal stem cell maintenance and homeostasis
by: Li Yang, et al.
Published: (2025-02-01) -
Research projects: 2017-2021
by: Kabale University
Published: (2023)